Engineering Protein–Nanoparticle Hybrids as Targeted Contrast Agents

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-24
DOI
https://doi.org/10.5281/zenodo.14041240
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engineering Protein–Nanoparticle Hybrids as Targeted Contrast Agents

Zenodo (CERN European Organization for Nuclear Research)
Nanoparticle-Based Drug Delivery
article

Engineering Protein–Nanoparticle Hybrids as Targeted Contrast Agents

article en

Abstract

No abstract available for this paper.
Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 56%
Nanoparticle-Based Drug Delivery
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Engineering Protein–Nanoparticle Hybrids as Targeted Contrast Agents · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS